drugset / Trial / NCT05353972
Evaluate IMG-007 in Healthy Participants
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This first in human (FIH) study will evaluate the safety, tolerability, pharmacokinetics (PK)), and immunogenicity of a single ascending dose of IMG-007 in healthy participants.
Timeline
- Start
- 2022-07-05
- Primary completion
- 2023-05-31
- Completion
- 2023-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IMG-007 | Unknown | — | Intravenous |
Indications
No indication recorded.